Cargando…
A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria
Autores principales: | James, Onyemata E., Johanna, Ledwaba, Rawlings, Datir, Babajehson, M., Ashrad, Ismail, Anne, Derache, Abimiku, Alash’le, Dakum, Patrick, Gillian, Hunt, Ndembi, Nicaise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565984/ https://www.ncbi.nlm.nih.gov/pubmed/28845272 http://dx.doi.org/10.1093/ve/vew036.022 |
Ejemplares similares
-
A3 Molecular epidemiology of HIV-1 in Nigeria
por: Nazziwa, J, et al.
Publicado: (2019) -
Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread
por: Nazziwa, Jamirah, et al.
Publicado: (2020) -
Prevalence of hypertension among patients aged 50 and older living with human immunodeficiency virus
por: Dakum, Patrick, et al.
Publicado: (2019) -
Performance and trend for quality of service in a large HIV/AIDS treatment program in Nigeria
por: Aliyu, Ahmad, et al.
Publicado: (2019) -
Evaluation of the reproducibility of amplicon sequencing with Illumina MiSeq platform
por: Wen, Chongqing, et al.
Publicado: (2017)